What we know so far about a cell protein called SERINC2
Original title: SERINC2: From membrane lipid synthesis to human disease.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a review of where the science stands, not a new treatment.
The short version
This paper pulls together past studies on a protein called SERINC2 and disease.
What was studied. Researchers reviewed earlier studies about SERINC2, a protein that helps build fats in cell membranes. They searched three research databases for work published up to 2026.
What they found. In some cancers, such as lung and cervical cancer, SERINC2 was linked to tumor cells growing and moving. In glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary, a brain tumor, the evidence is only a link. The authors also report links to heart problems and to brain and mood conditions. They say direct proof of how it works is still limited.
What this means, and what it doesn't
What it could mean: For now this is background science, not care. It may guide future research. Scientists want to know if SERINC2 could become a useful test or a drug target.
What it doesn't mean: This is not a new treatment and it is not a cure. It is a review of past lab and gene studies, not a trial in people. For glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary, the authors say the evidence is only a link. That does not show this protein causes the tumor or can be treated. Nothing here changes the care you get today.
Source: PubMed, October 2, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.